The cancer patient's journey: An uphill climb

October 21, 2004

Europe's leading cancer charity and the first cancer survivor ever to reach the summit of Mount Everest have teamed up to help others get the best help possible in the fight against cancer.

On 31 October, Sean Swarner will be speaking at the European Society for Medical Oncology's 3rd Patient Seminar, a meeting that provides a vital opportunity for cancer patients to hear about the latest in treatments from the world's top cancer doctors. The seminar makes the most of the fact that hundreds of leading oncologists are gathering for the 29th ESMO Congress to give cancer patients the latest news about chemotherapy and drugs. There are few fields in clinical medicine that are expanding as rapidly as oncology. "The patient seminar is a really fantastic idea, and I'm proud to be involved with it," Sean said. "I really wish something like this had been around in the early days for me."

Sean was diagnosed with final stage Hodgkin's disease at the age of 13, and given 3 months to live. After 10 months of chemotherapy the cancer went into remission, but just 18 months later doctors found a golf-ball sized tumor in his chest and told him he had just 14 days left to live.

Fourteen years later, he climbed Mt. Everest, the world's highest peak. "I remember when I was fighting cancer and all my friends were chasing girls, collecting baseball cards, and trying different styles with their hair - I had no hair," says Sean. "I had no girls who were interested in me because I was 60 lbs overweight, and I had no one to look up to, no models to encourage me. I felt so alone." "Climbing Everest was an attempt to become that support, that model, that encouragement, that inspiration to others who might not have someone to look up to," Sean says. "I wanted to become a beacon of hope to those battling cancer. I wanted to provide inspiration that they too can 'climb' out of their existing life and into an incredible one after the disease."

Sean's own personal climbing journey hasn't stopped either. He is now President and Co-founder of the non-profit organization, CancerClimber and is attempting to climb 'The 7-Summits'--the highest mountain on each continent. On every mountain he climbs, he plants a flag that says, 'Dedicated to all those affected by cancer in this small world! Keep climbing!'

As a sign of solidarity with all cancer patients, Sean plans to visit the Vienna Wilhelminen Hospital on Wednesday, 27 October 2004. Prof. Heinz Ludwig, Head of the Department of Medicine and Medical Oncology, looks forward to welcoming Sean Swarner and using his visit to raise awareness of the urgent need to increase cancer research and funding.

Sean Swarner is available for interviews on-site during the ESMO Congress. He will also be visiting the Wilhelminen Hospital in Vienna before the Patient Seminar, where he will be speaking with patients, and participate in the Press Conference 1, Sat. 30 October, 12:45-13:45, Austria Center, Vienna, Austria
-end-
For further information please contact: ESMO Press Room (29 October - 2 November)
Tel. 43-1-260-69-2020
Fax +3-1-260-69-2604

Gracemarie Bricalli
ESMO Communication Manager
Mobile 41-79-77-851-77
E-mail gracemarie@esmo.org

Vanessa Pavinato
ESMO Communication Assistant
Mobile 41-76-305-82-68
E-mail vanessa@esmo.org

European Society for Medical Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.